Synthone Laboratories And Consultants Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 28-12-2024
- Paid Up Capital ₹ 0.11 M
as on 28-12-2024
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 142.38%
(FY 2023)
- Profit 2287.92%
(FY 2023)
- Ebitda 10222.99%
(FY 2023)
- Net Worth 57.77%
(FY 2023)
- Total Assets 86.07%
(FY 2023)
About Synthone Laboratories And Consultants
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Varadarajan Venkatraman, Sandhya Tatke, and Digambar Tatke serve as directors at the Company.
- CIN/LLPIN
U99999MH1988PTC049324
- Company No.
049324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Synthone Laboratories And Consultants?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varadarajan Venkatraman  | Director | 16-Feb-1995 | Current |
| Sandhya Tatke | Director | 16-Feb-1995 | Current |
| Digambar Tatke | Director | 21-Oct-1988 | Current |
Financial Performance of Synthone Laboratories And Consultants.
Synthone Laboratories And Consultants Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 142.38% increase. The company also saw a substantial improvement in profitability, with a 2287.92% increase in profit. The company's net worth Soared by an impressive increase of 57.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synthone Laboratories And Consultants?
In 2023, Synthone Laboratories And Consultants had a public holding of 52.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarveshwar Chemicals Private LimitedActive 34 years 3 monthsSandhya Tatke and Digambar Tatke are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synthone Laboratories And Consultants?
Unlock and access historical data on people associated with Synthone Laboratories And Consultants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synthone Laboratories And Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthone Laboratories And Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
